Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Neptune Digital Assets Corp. NDA Apr 25, 2025 1.75 +16.67   
 NervGen Pharma Corp Common Stock (Canada) NGEN Apr 25, 2025 2.95 -0.67   
 Network Media Group NTE Apr 25, 2025 0.07 0.00   
 NeuPath Health Inc NPTH Apr 25, 2025 0.20 +2.63   
 Nevada King Gold Corp NKG Apr 25, 2025 0.24 0.00   
 Nevada Lithium Resources Inc NVLH Apr 25, 2025 0.16 0.00   
 Nevada Sunrise Metals Corporation NEV Apr 25, 2025 0.02 0.00   
 Nevgold Corp NAU Apr 25, 2025 0.32 -7.35   
 New Age Metals NAM Apr 25, 2025 0.11 -8.70   
 New Destiny Mining Corp NED Apr 25, 2025 0.04 -22.22   
 New Energy Metals ENRG Apr 25, 2025 0.26 0.00   
 New Found Gold NFG Apr 25, 2025 1.57 +1.29   
 New Gold NGD Apr 25, 2025 4.70 -2.49   
 New Pacific Metals NUAG Apr 25, 2025 1.70 +4.29   
 New Stratus Energy Inc NSE Apr 25, 2025 0.36 -7.69   
 New Zealand Energy NZ Apr 25, 2025 0.28 0.00   
 Newcore Gold Ltd. NCAU Apr 25, 2025 0.57 0.00   
 Newmont NGT Apr 25, 2025 74.73 -3.22   
 Newport Exploration Ltd NWX Apr 25, 2025 0.12 -8.00   
 Newtopia Inc NEWU Apr 25, 2025 0.01 0.00   
 NEXE Innovations Inc NEXE Apr 25, 2025 0.23 +2.27   
 Nexera Energy Inc NGY Apr 25, 2025 0.02 0.00   
 NexGen NXE Apr 25, 2025 7.05 -0.42   
 Nexgenrx Inc NXG Apr 25, 2025 0.29 0.00   
 NexGold Mining NEXG Apr 25, 2025 0.74 0.00   
 NexLiving Communities Inc NXLV Apr 25, 2025 1.70 0.00   
 NexPoint Hospitality Trust Unit NHT.U Apr 25, 2025 0.33 0.00   
 Next Hydrogen Solutions Inc NXH Apr 25, 2025 0.73 0.00   
 NextSource Materials Inc NEXT Apr 25, 2025 0.28 -3.45   
 Nexus Gold Corp. NXS Apr 25, 2025 0.01 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.